Kane Biotech Inc. V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

TSXV:KNE - Post by User

Kane Biotech Inc.

Bullboard Posts

Comment by Pokerchampon Apr 09, 2016 11:40am

34 Views

Post# 24748032

RE:Oh, The Games Played Here

You're wrong. This is all working perfectly. Giving Renaud total control is the sole purpose of this exercise, so from Renaud's perspective it's working out as intended. He'll not only exercise his rights but pick up all that's left unexercised plus buy the few sold. And he keeps collecting his loan interest in shares. Another month and he'll probably hold 60%. What he then does with the company is another question. One thing is for sure, he's not a charity.

beenthere wrote: Soon to be 3 whole cents.
Then what are these rights worth?
The easy answer is ZERO!!

The pp didn't work. ZERO interest.
Why would they think this rights offering would work??
STUPID!
What a waste of the company funds!
The only possible answer ....
For this is to help you know how take this company private.